JOINT Corp
No enriched coverage for $JYNT in the last 7 days.
No SEC Form 4 filings for $JYNT in the last 30 days.
See all $JYNT insider activity →The Joint Corp. (JYNT) reacquired regional developer rights in Texas, adding to a series of 2026 territory reacquisitions. These moves represent over 150 potential new clinics, advancing the company's shift to a pure-play franchisor model. The strategy aims to strengthen franchisee support and expand the brand's footprint.
JOINT Corp reacquired Texas regional development rights for $8.0M in cash, with up to $2.0M in earnouts tied to sales. The deal, effective October 1, 2026, includes 141 franchised clinics and aims to simplify royalties and enhance market control. The company terminated existing Texas regional developer agreements mutually.
JOINT Corp (JYNT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into a Material Definitive Agreement. On October 1, 2026, we entered into an Asset Purchase Agreement (the “APA”) with The Joint Franchises San Antonio, LLC, a Texas limited liability company, The Joint Franchises DFW, LLC, a Texas limited liability company, The
Recent JYNT coverage spans financial news, mergers & acquisitions and corporate actions.
Positive outlook as the company regains direct control over franchise development, potentially boosting revenue and earnings.
The acquisition consolidates Texas operations, likely improving royalty efficiency and control.
The transaction expands JOINT Corp's control over 141 Texas clinics, potentially improving future royalty streams and operational leverage.
Results and cash flow improved alongside a capital-light refranchising push, supporting a margin and buyback narrative.
Clinic opening supports incremental unit growth narrative for JYNT’s franchise/managed network, but provides no financial guidance or quantified impact.
AlphAI scores every news story that mentions JYNT with an AI model for sentiment and relevance, and aggregates insider trades from JOINT Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
The Joint Corp. (JYNT) reacquired regional developer rights in Texas, adding to a series of 2026 territory reacquisitions. These moves represent over 150 potential new clinics, advancing the company's shift to a pure-play franchisor model. The strategy aims to strengthen franchisee support and expand the brand's footprint.
2 min readJOINT Corp reacquired Texas regional development rights for $8.0M in cash, with up to $2.0M in earnouts tied to sales. The deal, effective October 1, 2026, includes 141 franchised clinics and aims to simplify royalties and enhance market control. The company terminated existing Texas regional developer agreements mutually.
1 min readJOINT Corp (JYNT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into a Material Definitive Agreement. On October 1, 2026, we entered into an Asset Purchase Agreement (the “APA”) with The Joint Franchises San Antonio, LLC, a Texas limited liability company, The Joint Franchises DFW, LLC, a Texas limited liability company, The
1 min readJOINT Corp (JYNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 The Joint Corp. Reports Second Quarter 2026 Financial Results - Consolidated Net Income Increases $560,000 to $653,000; Adjusted EBITDA From Continuing Operations Increases by $1.4 Million - - Cash Flow from Operating Activities Rises 152% to $2.2 Million, Driving Fr
5 min readThe Joint Corp. (NASDAQ: JYNT) said it opened a new The Joint Chiropractic clinic in Warwick, Rhode Island, its 44th state. The location is owned by Sarah and Yosef Perfido, multi-unit franchise operators. The company cited a network of 950+ clinics and 14 million patient visits annually, and said it plans further expansion.
3 min readJoint Corp (JYNT) director Ronald V. DaVella has been granted 5,714 restricted shares of common stock as an equity award, with no purchase price. These shares will fully vest on the earlier of May 20, 2027, or the date of the next annual stockholders' meeting. Following this transaction, DaVella's direct holdings in Joint Corp amount to 23,243 common shares.
2 min readJoint Corp (JYNT) director Christopher M. Grandpre was granted 5,714 restricted shares of Common Stock as an equity award. These shares, with a grant price of $0.00, will vest in full on the earlier of May 20, 2027, or the date of the next annual stockholders' meeting. Following this grant, Grandpre directly holds a total of 45,097 Common Stock shares.
2 min readJOINT Corp director Matthew E. Rubel was granted 5,714 restricted shares of Common Stock as compensation, increasing his direct holdings to 23,177 shares. These shares were acquired at $0.00 per share and will vest fully on the earlier of May 20, 2027, or the date of the next annual stockholders' meeting.
2 min readThe Joint Corp. (NASDAQ:JYNT) has sold 45 corporate-managed chiropractic clinics in Southern California to Elite Chiro Group for approximately $2.3 million, as part of a strategic shift to a capital-light, pure-play franchisor model. This transaction significantly reduces the company's corporate-managed clinics and aligns with "The Joint 2.0" growth strategy. Analysts predict profitability this year and an EPS forecast of $0.29 for fiscal 2026, supported by the company's strong gross profit margin.
2 min readRoth Capital lowered its price target for Joint Corp. (JYNT) to $12 from $14, while maintaining a Buy rating. This decision follows Joint Corp.'s Q4 results exceeding estimates and 2026 guidance largely aligning with Roth's model. However, the analyst expressed that management's post-refranchising pro forma model is "underwhelming" despite long-term upside potential.
2 min read
